Genocea Biosciences, Inc. announced that Seth Hetherington, M.D. delivered his resignation as Chief Medical Officer of the company, effective immediately. Dr. Hetherington, an infectious disease expert, is leaving the company in connection with the company’s strategic shift to focus on oncology and the development of cancer vaccines. The company has commenced a search for a new Chief Medical Officer with an executive search firm.